Development and Initial Clinical Experience with AltaSeal®: a Novel Hysteroscopically Placed Permanent Contraception System

[1]  E. Schiff,et al.  In Vitro Fertilization Outcomes After Placement of Essure Microinserts in Patients With Hydrosalpinges Who Previously Failed In Vitro Fertilization Treatment: A Multicenter Study. , 2016, Journal of minimally invasive gynecology.

[2]  T. Lawrie,et al.  Techniques for the interruption of tubal patency for female sterilisation. , 2016, The Cochrane database of systematic reviews.

[3]  I. Thompson,et al.  Postpartum Care and Contraception in Obese Women , 2016, Clinical obstetrics and gynecology.

[4]  Kenneth J. Smith,et al.  Hysteroscopic Essure Inserts for Permanent Contraception: Extended Follow-Up Results of a Phase III Multicenter International Study. , 2016, Journal of minimally invasive gynecology.

[5]  J. Jensen,et al.  Update on permanent contraception options for women , 2015, Current opinion in obstetrics & gynecology.

[6]  J. Jensen,et al.  Permanent Contraception for Women , 2015, Women's health.

[7]  S. Veersema Hysteroscopy and contraception. , 2015, Best practice & research. Clinical obstetrics & gynaecology.

[8]  H. Brölmann,et al.  Effectiveness and feasibility of hysteroscopic sterilization techniques: a systematic review and meta-analysis. , 2015, Fertility and sterility.

[9]  P. Crean,et al.  First clinical experience with Celt ACD(®) : a femoral arterial puncture closure device. , 2013, Journal of interventional cardiology.

[10]  W. Mosher,et al.  Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995. , 2012, National health statistics reports.

[11]  M. Gannon I122 FIRST CLINICAL RESULTS OF NEW HYSTEROSCOPIC STERILISATION DEVICE: ALTASEAL , 2012 .

[12]  A. Thurkow AltaSeal Hysteroscopic Sterilization: The New Challenger to Essure? , 2011 .

[13]  M. Bongers,et al.  Success Rate of the Adiana® Hysteroscopic Sterilization Technique , 2011 .

[14]  T. Anderson,et al.  The Adiana System for permanent contraception: safety and efficacy at 3 years. , 2011, Journal of minimally invasive gynecology.

[15]  D. Galen,et al.  Essure multicenter off-label treatment for hydrosalpinx before in vitro fertilization. , 2011, Journal of minimally invasive gynecology.

[16]  Andrea Meyer-Lindenberg,et al.  Evaluation of the soft tissue biocompatibility of MgCa0.8 and surgical steel 316L in vivo: a comparative study in rabbits , 2010, Biomedical engineering online.

[17]  T. Santonen,et al.  Review on toxicity of stainless steel , 2010 .

[18]  D. Kothwala,et al.  Development and assessment of 316LVM cardiovascular stents , 2004 .

[19]  C. Carignan,et al.  Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study. , 2001, Fertility and sterility.

[20]  H. Peterson,et al.  Complications of Interval Laparoscopic Tubal Sterilization: Findings From the United States Collaborative Review of Sterilization , 2000, Obstetrics and gynecology.